Estradiol and neurodegenerative oxidative stress

[1]  R. Irwin,et al.  Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function , 2006, BMC Neuroscience.

[2]  Yaxuan Sun,et al.  Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure. , 2006, Acta biochimica et biophysica Sinica.

[3]  R. Brinton,et al.  Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. , 2006, Endocrinology.

[4]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[5]  G. Perry,et al.  Therapeutic opportunities in Alzheimer disease: one for all or all for one? , 2005, Current medicinal chemistry.

[6]  C. Masters,et al.  Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.

[7]  G. Drewes MARKing tau for tangles and toxicity. , 2004, Trends in biochemical sciences.

[8]  R. Brinton,et al.  Mitochondria as therapeutic targets of estrogen action in the central nervous system. , 2004, Current drug targets. CNS and neurological disorders.

[9]  S. Shumaker,et al.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[10]  Roberta Diaz Brinton,et al.  Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons , 2004, Brain Research.

[11]  J. Simpkins,et al.  Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats* , 2004, Journal of Biological Chemistry.

[12]  Dick F. Swaab,et al.  Colocalization and alteration of estrogen receptor-α and -β in the hippocampus in Alzheimer’s disease , 2004 .

[13]  G. Audesirk,et al.  β-estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process , 2003, Neuroscience.

[14]  R. Ravid,et al.  Estrogen receptor α-immunoreactive astrocytes are increased in the hippocampus in Alzheimer’s disease , 2003, Experimental Neurology.

[15]  D. Sparks,et al.  Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Ravid,et al.  Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients , 2003, Acta Neuropathologica.

[17]  Kazuyuki Takata,et al.  Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.

[18]  J. Sweatt,et al.  Mitochondrial Regulation of Synaptic Plasticity in the Hippocampus* , 2003, The Journal of Biological Chemistry.

[19]  D. Pfaff,et al.  Immunolocalization of estrogen receptor β in the mouse brain: Comparison with estrogen receptor α , 2003 .

[20]  B. Sherwin,et al.  Estrogen and cognitive functioning in women. , 2003, Endocrine reviews.

[21]  G. Perry,et al.  Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells , 2003, Journal of neuroscience research.

[22]  R. Maccioni,et al.  Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures , 2003, Biometals.

[23]  J. Sastre,et al.  Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.

[24]  Roberta Diaz Brinton,et al.  Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Goodenough,et al.  Estrogen-induced cell signalling in a cellular model of Alzheimer’s disease , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  T. Horvath,et al.  Estrogen, synaptic plasticity and hypothalamic reproductive aging , 2003, Experimental Gerontology.

[27]  H. Fillit,et al.  Tau and Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[28]  P. Zandi,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[29]  D. Swaab,et al.  Increased p75NTR Expression in Hippocampal Neurons Containing Hyperphosphorylated τ in Alzheimer Patients , 2002, Experimental Neurology.

[30]  I. Grundke‐Iqbal,et al.  Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β , 2002, FEBS letters.

[31]  M. Brockhaus,et al.  The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion , 2002, Neuroscience.

[32]  D. Butterfield,et al.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.

[33]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[34]  Lixia Zhao,et al.  Neuroprotective and Neurotrophic Efficacy of Phytoestrogens in Cultured Hippocampal Neurons , 2002, Experimental biology and medicine.

[35]  K. Davies,et al.  Protein turnover by the proteasome in aging and disease. , 2002, Free radical biology & medicine.

[36]  C. Lauderback,et al.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .

[37]  G. Perry,et al.  Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? , 2002, Neurochemistry International.

[38]  Roberta Diaz Brinton,et al.  Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway , 2002, Brain Research.

[39]  D. Price,et al.  High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal* , 2002, The Journal of Biological Chemistry.

[40]  H. Vinters,et al.  The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease , 2002, Brain pathology.

[41]  J. Land,et al.  β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities , 2001, Journal of neurochemistry.

[42]  C. Pike,et al.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.

[43]  P. Wise,et al.  Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies , 2001, Brain Research Reviews.

[44]  R. Ravid,et al.  Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer’s disease , 2001, Brain Research.

[45]  V. Calabrese,et al.  Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.

[46]  R. Curi,et al.  Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[47]  J. Simpkins,et al.  Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3‐nitroproprionic acid in SK‐N‐SH human neuroblastoma cells , 2001, Journal of neurochemistry.

[48]  A. Deckel Nitric oxide and nitric oxide synthase in Huntington's disease , 2001, Journal of neuroscience research.

[49]  I. Mook‐Jung,et al.  Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells , 2001, Neuroscience Letters.

[50]  B. McEwen,et al.  Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women. , 2001, Postgraduate medicine.

[51]  W. Markesbery,et al.  Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures , 2001, Neurobiology of Aging.

[52]  M. Kindy,et al.  Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury , 2001 .

[53]  J. Parks,et al.  Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.

[54]  E. Cadenas,et al.  Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. , 2001, The Biochemical journal.

[55]  B. McEwen,et al.  Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites , 2001 .

[56]  G. Perry,et al.  Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal , 2000, FEBS letters.

[57]  J. Kuret,et al.  Oxidative regulation of fatty acid-induced tau polymerization. , 2000, Biochemistry.

[58]  J W Yates,et al.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.

[59]  K. Ley,et al.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.

[60]  I. Merchenthaler,et al.  Evidence for novel estrogen binding sites in the rat hippocampus , 2000, Neuroscience.

[61]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[62]  J. Simpkins,et al.  Neuroprotective effects of estrogens: potential mechanisms of action , 2000, International Journal of Developmental Neuroscience.

[63]  R. Brinton,et al.  The women’s health initiative estrogen replacement therapy is neurotrophic and neuroprotective , 2000, Neurobiology of Aging.

[64]  S. Rajaratnam,et al.  An approach to postmenopausal osteoporosis. , 2000, National Medical Journal of India.

[65]  J. Blass,et al.  Inherent Abnormalities in Energy Metabolism in Alzheimer Disease: Interaction with Cerebrovascular Compromise , 2000, Annals of the New York Academy of Sciences.

[66]  G. Mor,et al.  Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. , 2000, Journal of neurobiology.

[67]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[68]  I. Merchenthaler,et al.  Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain , 2000, Neuroscience.

[69]  M. Murakoshi,et al.  Regulation of prostatic glutathione-peroxidase (GSH-PO) in rats treated with a combination of testosterone and 17 beta-estradiol. , 1999, The Journal of toxicological sciences.

[70]  B. Paquette,et al.  DNA damage induced by catecholestrogens in the presence of copper (II): generation of reactive oxygen species and enhancement by NADH. , 1999, Free radical biology & medicine.

[71]  F. Holsboer,et al.  The female sex hormone oestrogen as a neuroprotectant. , 1999, Trends in pharmacological sciences.

[72]  T. Bates,et al.  β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.

[73]  P. Shughrue,et al.  Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors , 1999, The Journal of Neuroscience.

[74]  A. Delacourte Biochemical and Molecular Characterization of Neurofibrillary Degeneration in Frontotemporal Dementias , 1999, Dementia and Geriatric Cognitive Disorders.

[75]  J. York,et al.  Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Meharvan Singh,et al.  Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story , 1999, Frontiers in Neuroendocrinology.

[77]  D. Dorsa,et al.  The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.

[78]  Xiaoping Guan,et al.  Estrogen-Induced Activation of Mitogen-Activated Protein Kinase in Cerebral Cortical Explants: Convergence of Estrogen and Neurotrophin Signaling Pathways , 1999, The Journal of Neuroscience.

[79]  D. Roy,et al.  Concentration dependence of prooxidant and antioxidant properties of catecholestrogens. , 1998, Archives of biochemistry and biophysics.

[80]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[81]  S. Finklestein,et al.  Estradiol Protects against Ischemic Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  M. Beal,et al.  Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.

[83]  D. Dorsa,et al.  Modulation of Bcl‐2 expression: a potential component of estrogen protection in NT2 neurons , 1998, Neuroreport.

[84]  T. Arendt,et al.  The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease , 1998, Neuroscience.

[85]  J. Weisz,et al.  Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer. , 1998, Carcinogenesis.

[86]  A. Day,et al.  Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats , 1998, Brain Research.

[87]  A. Conney,et al.  Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? , 1998, Cancer research.

[88]  G. Mor,et al.  Raloxifene Induces Neurite Outgrowth in, Estrogen Receptor Positive PC 12 Cells , 1998, Menopause.

[89]  K. Imahori,et al.  Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. , 1998, Biochimica et biophysica acta.

[90]  L. Amaducci,et al.  Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging , 1998, Neurology.

[91]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[92]  J. Simpkins,et al.  Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione , 1998, Neuroscience.

[93]  M. Mattson,et al.  Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. , 1997, Neuroreport.

[94]  M. Mattson,et al.  17β‐Estradiol attenuates oxidative impairment of synaptic Na+/K+‐ATPase activity, glucose transport, and glutamate transport induced by amyloid β‐peptide and iron , 1997, Journal of neuroscience research.

[95]  R. Brinton,et al.  17 β-Estradiol Enhances the Outgrowth and Survival of Neocortical Neurons in Culture , 1997, Neurochemical Research.

[96]  J. Simpkins,et al.  Phenolic A ring requirement for the neuroprotective effects of steroids , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[97]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[98]  K. Patil,et al.  Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[99]  S. Kato,et al.  Rapid activation of MAP kinase by estrogen in the bone cell line. , 1997, Biochemical and biophysical research communications.

[100]  R. Brookmeyer,et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease , 1997, Neurology.

[101]  V. Henderson The epidemiology of estrogen replacement therapy and Alzheimer's disease , 1997, Neurology.

[102]  F. Holsboer,et al.  Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.

[103]  D. Hanger,et al.  Oxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures , 1997 .

[104]  J. Liehr,et al.  Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[105]  S. Budd,et al.  Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 1996, Journal of neurochemistry.

[106]  F. Fazekas,et al.  Estrogen Replacement Therapy In Older Women: A Neuropsychological And Brain MRI Study , 1996, Journal of the American Geriatrics Society.

[107]  I. Reynolds,et al.  Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.

[108]  S. Thayer,et al.  Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons. , 1996, Journal of neurophysiology.

[109]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[110]  D. Selkoe,et al.  Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[111]  D. Dorsa,et al.  Estrogen protects primary cortical neurons from glutamate toxicity , 1996, Neuroscience Letters.

[112]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. Paganini-Hill Oestrogen replacement therapy and Alzheimer's disease. , 1996, British journal of obstetrics and gynaecology.

[114]  F. Holsboer,et al.  17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. , 1995, Biochemical and biophysical research communications.

[115]  J. Liehr,et al.  Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. , 1995, Carcinogenesis.

[116]  J. C. Chisholm,et al.  The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. , 1995, Journal of neurobiology.

[117]  B. Ames,et al.  Oxidative damage and mitochondrial decay in aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J. Woodgett,et al.  Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. , 1994, The Biochemical journal.

[119]  J. Yesavage,et al.  Estrogen Replacement Therapy and Memory in Older Women , 1994, Journal of the American Geriatrics Society.

[120]  K. Gunter,et al.  Mitochondrial calcium transport: physiological and pathological relevance. , 1994, The American journal of physiology.

[121]  B. Sherwin,et al.  Estrogen Use and Verbal Memory in Healthy Postmenopausal Women , 1994, Obstetrics and gynecology.

[122]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Bockaert,et al.  NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.

[124]  Charles Tator,et al.  Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo , 1993, Neuron.

[125]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[126]  D. Choi,et al.  Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[127]  Mark P. Mattson,et al.  Calcium as sculptor and destroyer of neural circuitry , 1992, Experimental Gerontology.

[128]  M. Beal Mechanisms of excitotoxicity in neurologic diseases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[129]  C. Cotman,et al.  β-Amyloid neurotoxicity: A discussion of in vitro findings , 1992, Neurobiology of Aging.

[130]  M. Mattson,et al.  Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF , 1992, Experimental Neurology.

[131]  H. Strobel,et al.  Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. , 1992, Archives of biochemistry and biophysics.

[132]  B. Mcewen,et al.  Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat [published erratum appears in J Neurosci 1992 Oct;12(10):following table of contents] , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[133]  J. Joseph The putative role of free radicals in the loss of neuronal functioning in senescence , 1992, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.

[134]  Samuel Thayer,et al.  Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[135]  H. Sies Role of reactive oxygen species in biological processes , 1991, Klinische Wochenschrift.

[136]  A. Ferreira,et al.  Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[137]  M. Nakano,et al.  Stopped-flow investigation of antioxidant activity of estrogens in solution. , 1990, Biochimica et biophysica acta.

[138]  R. Black,et al.  Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. , 1990, Archives of neurology.

[139]  D. Roy,et al.  The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. , 1990, Carcinogenesis.

[140]  A. Young,et al.  Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.

[141]  M. Dempsey,et al.  Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. , 1989, The Journal of biological chemistry.

[142]  J. Weisz,et al.  Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. , 1989, Endocrinology.

[143]  M. Nakano,et al.  Mechanism of O2- generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems. , 1988, Biochimica et biophysica acta.

[144]  D. Choi,et al.  N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. , 1987, The Journal of pharmacology and experimental therapeutics.

[145]  E. Niki,et al.  Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. , 1987, Biochemical and biophysical research communications.

[146]  D. Choi Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[147]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[148]  J. Olney,et al.  Glutamate and the pathophysiology of hypoxic–ischemic brain damage , 1986, Annals of neurology.

[149]  F. Naftolin,et al.  Anovulation in female rats induced by neonatal administration of the catechol estrogens, 2-hydroxy-estradiol and 4-hydroxy-estradiol. , 1983, Neuroendocrinology.

[150]  F. Naftolin,et al.  The effects of oestrogen on hypothalamic tissue. , 1978, Ciba Foundation symposium.

[151]  H Breuer,et al.  Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. , 1972, The Journal of clinical endocrinology and metabolism.

[152]  S. Goldstein,et al.  Binding of calcium by liver mitochondria of rats treated with steroid hormones. , 1966, The Journal of biological chemistry.

[153]  Meharvan Singh Ovarian hormones elicit phosphorylation of akt and extracellular-signal regulated kinase in explants of the cerebral cortex , 2007, Endocrine.

[154]  C. Christiansen,et al.  Early postmenopausal hormone therapy may prevent cognitive impairment later in life , 2005, Menopause.

[155]  B. McEwen Estrogen actions throughout the brain. , 2002, Recent progress in hormone research.

[156]  D. Selkoe Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. , 2001, Journal of Alzheimer's disease : JAD.

[157]  T. Arendt,et al.  Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat. , 1998, Journal fur Hirnforschung.

[158]  H. Schipper Gomori‐positive astrocytes: Biological properties and implications for neurologic and neuroendocrine disorders , 1991, Glia.

[159]  J. Liehr,et al.  Free radical generation by redox cycling of estrogens. , 1990, Free radical biology & medicine.

[160]  C. Léránth,et al.  The cellular effects of estrogens on neuroendocrine tissues. , 1988, Journal of steroid biochemistry.

[161]  J. Cabezas,et al.  Effects of oestradiol, testosterone and medroxyprogesterone on subcellular fraction marker enzyme activities from rat liver and brain. , 1985, Comparative biochemistry and physiology. B, Comparative biochemistry.